ACBP/DBI neutralization for the prevention and treatment of malignant and non-malignant liver diseases

作者
Sijing Li,Flavia Lambertucci,Léa Montégut,Isabelle Duran Martins,Jonathan Pol,Mauro Piacentini,Maria Chiara Maiuri,Guido Kroemer
出处
期刊:Cell Death and Disease [Springer Nature]
卷期号:16 (1)
标识
DOI:10.1038/s41419-025-08148-0
摘要

Abstract Acyl coenzyme A binding protein (ACBP), also known as diazepam binding inhibitor (DBI), suppresses autophagy, stimulates food intake, and regulates body composition. This tissue hormone contributes to the development of age-related diseases such as metabolic syndrome, cardiovascular disease, cancer, and osteoarthritis. ACBP/DBI also plays a key pathogenic role in liver disorders, including hepatocellular carcinoma (HCC). Circulating levels of ACBP/DBI are elevated in patients with histologically diagnosed steatosis, liver fibrosis or HCC, and correlate with disease severity. Moreover, the incidence of liver cancers increases in individuals receiving benzodiazepines, which act on the same binding sites of the GABA-A receptor as ACBP/DBI. In mice, inhibiting ACBP/DBI, via inducible knockout, mutation of its receptor (the γ2 subunit of the GABA-A receptor) or antibody-mediated neutralization, alleviates various liver conditions, including ischemia-reperfusion injury, bile duct obstruction, hepatotoxicity of acetaminophen, CCl 4 , ethanol, or concanavalin A, metabolic dysfunction-associated fatty liver disease, and HCC. Importantly, the anti-tumor effects of ACBP/DBI neutralization are not solely due to its hepatoprotective properties, as they persist in mouse models of HCC driven by oncogenes (e.g., β-catenin and MYC) or orthotopic injection of syngeneic liver cancer cells into immunocompetent hosts. Notably, hepatocellular carcinoma (HCC) is one of the few cancers in which elevated local ACBP/DBI expression is associated with poor clinical prognosis. In sum, ACBP/DBI functions as both a biomarker and a potential therapeutic target for malignant and non-malignant liver diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
顾矜的应助被公爵采纳,获得20
1秒前
Yuan88发布了新的文献求助10
1秒前
研友_VZG7GZ的应助被drizzle采纳,获得10
2秒前
nwy发布了新的文献求助10
2秒前
3秒前
ringo发布了新的文献求助10
3秒前
3秒前
369ninja发布了新的文献求助10
3秒前
3秒前
Yuan88发布了新的文献求助10
4秒前
Hello的应助被勤恳鹤采纳,获得10
5秒前
orixero的应助被梨涡采纳,获得10
5秒前
XJ发布了新的文献求助10
5秒前
搜集达人的应助被腼腆的立诚采纳,获得10
6秒前
6秒前
包包琪完成签到 ,获得积分10
7秒前
7秒前
Yuan88发布了新的文献求助10
7秒前
maolei69发布了新的文献求助10
8秒前
swimming发布了新的文献求助100
9秒前
lin发布了新的文献求助10
9秒前
mango完成签到,获得积分10
10秒前
10秒前
10秒前
10秒前
公爵发布了新的文献求助20
11秒前
Re0pen发布了新的文献求助10
12秒前
毛毛发布了新的文献求助10
12秒前
12秒前
斯文败类的应助被maolei69采纳,获得10
13秒前
SciGPT的应助被徐枘采纳,获得10
13秒前
阿松发布了新的文献求助10
13秒前
Yuan88发布了新的文献求助10
14秒前
15秒前
16秒前
16秒前
Yuan88发布了新的文献求助10
17秒前
Echo完成签到,获得积分20
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184220
求助须知:如何正确求助?哪些是违规求助? 9573266
关于积分的说明 21830447
捐赠科研通 7781246
什么是DOI,文献DOI怎么找? 3434248
关于科研通互助平台的介绍 2558373
邀请新用户注册赠送积分活动 2480784